INVITRO SYNERGISM BETWEEN A NOVEL AMPHIBIAN OOCYTIC RIBONUCLEASE (ONCONASE(R)) AND TAMOXIFEN, LOVASTATIN AND CISPLATIN, IN HUMAN OVCAR-3 OVARIAN-CARCINOMA CELL-LINE

  • Authors:
    • SM MIKULSKI
    • A VIERA
    • K SHOGEN
  • View Affiliations

  • Published online on: December 1, 1992     https://doi.org/10.3892/ijo.1.7.779
  • Pages: 779-785
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

In vitro tumor cell growth inhibitory and cytotoxic synergisms between a novel amphibian oocytic ribonuclease (ONCONASE)(ONC) and tamoxifen (TMX), lovastatin (LVT) and cisplatin (CDDP), have been observed in the human, estrogen and androgen receptor positive, chemotherapy-resistant NIH-OVCAR-3 ovarian carcinoma cell line. In view of the fact that the resistance to the available systemic chemotherapy represents one of the most important causes of treatment failure in patients with advanced ovarian cancer, the observed various forms of combination therapy synergisms suggest that these regimens could be tested in vivo, including human clinical trials. Particularly important are findings of significant synergistic tumor cell growth inhibitory and cytotoxic activities exerted by the combination of ONC with CDDP; NIH-OVCAR-3 cells are reportedly resistant to the latter. Of specific interest are the observed synergisms between ONC and TMX and between ONC and LVT, an inhibitor of the 3-hydroxy-3- methyl-glutaryl-CoA reductase which is a rate-limiting enzyme in the mevalonate/cholesterol synthesis pathway. A facilitation of apoptosis-induction by the drug combinations presently studied is discussed as a possible mechanism of the observed synergisms.

Related Articles

Journal Cover

December 1992
Volume 1 Issue 7

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
MIKULSKI, S., VIERA, A., & SHOGEN, K. (1992). INVITRO SYNERGISM BETWEEN A NOVEL AMPHIBIAN OOCYTIC RIBONUCLEASE (ONCONASE(R)) AND TAMOXIFEN, LOVASTATIN AND CISPLATIN, IN HUMAN OVCAR-3 OVARIAN-CARCINOMA CELL-LINE. International Journal of Oncology, 1, 779-785. https://doi.org/10.3892/ijo.1.7.779
MLA
MIKULSKI, S., VIERA, A., SHOGEN, K."INVITRO SYNERGISM BETWEEN A NOVEL AMPHIBIAN OOCYTIC RIBONUCLEASE (ONCONASE(R)) AND TAMOXIFEN, LOVASTATIN AND CISPLATIN, IN HUMAN OVCAR-3 OVARIAN-CARCINOMA CELL-LINE". International Journal of Oncology 1.7 (1992): 779-785.
Chicago
MIKULSKI, S., VIERA, A., SHOGEN, K."INVITRO SYNERGISM BETWEEN A NOVEL AMPHIBIAN OOCYTIC RIBONUCLEASE (ONCONASE(R)) AND TAMOXIFEN, LOVASTATIN AND CISPLATIN, IN HUMAN OVCAR-3 OVARIAN-CARCINOMA CELL-LINE". International Journal of Oncology 1, no. 7 (1992): 779-785. https://doi.org/10.3892/ijo.1.7.779